Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 6

pCR as a surrogate marker for

survival

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5 7,8,9,10,11,12,13,14,15,16,...47